Shanming Wu

754 total citations
11 papers, 268 citations indexed

About

Shanming Wu is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Shanming Wu has authored 11 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 9 papers in Hepatology and 1 paper in Infectious Diseases. Recurrent topics in Shanming Wu's work include Hepatitis B Virus Studies (9 papers), Hepatitis C virus research (7 papers) and Liver Disease Diagnosis and Treatment (7 papers). Shanming Wu is often cited by papers focused on Hepatitis B Virus Studies (9 papers), Hepatitis C virus research (7 papers) and Liver Disease Diagnosis and Treatment (7 papers). Shanming Wu collaborates with scholars based in China, Switzerland and Australia. Shanming Wu's co-authors include Xia-qiu Zhou, Mobin Wan, Chengzhong Li, Lungen Lu, Jiyao Wang, Jiqiang Li, Minde Zeng, Jian Jia, Jianren Gu and Xiong Cai and has published in prestigious journals such as Medicine, World Journal of Gastroenterology and Journal of Medical Virology.

In The Last Decade

Shanming Wu

11 papers receiving 259 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shanming Wu China	7	202	177	44	23	19	11	268
Mette Rye Clausen Denmark	10	121 0.6×	122 0.7×	28 0.6×	38 1.7×	12 0.6×	26	222
Giulio De Stefano Italy	4	175 0.9×	127 0.7×	65 1.5×	24 1.0×	30 1.6×	6	261
Toby Delahooke United Kingdom	8	208 1.0×	195 1.1×	43 1.0×	36 1.6×	15 0.8×	15	300
Keiko Korenaga Japan	9	171 0.8×	155 0.9×	45 1.0×	18 0.8×	18 0.9×	11	300
Chifumi Sato Japan	13	296 1.5×	339 1.9×	72 1.6×	24 1.0×	22 1.2×	15	447
Mobin Wan China	8	282 1.4×	256 1.4×	42 1.0×	55 2.4×	38 2.0×	15	362
Haoliang Wang China	8	116 0.6×	86 0.5×	32 0.7×	41 1.8×	22 1.2×	13	202
Ralph Gehrke Germany	4	293 1.5×	273 1.5×	66 1.5×	37 1.6×	33 1.7×	7	383
Ghada M. Salum Egypt	10	109 0.5×	101 0.6×	54 1.2×	11 0.5×	39 2.1×	28	235
Yunjie Dan China	11	185 0.9×	183 1.0×	45 1.0×	41 1.8×	60 3.2×	18	339

Countries citing papers authored by Shanming Wu

Since Specialization

Citations

This map shows the geographic impact of Shanming Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanming Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanming Wu more than expected).

Fields of papers citing papers by Shanming Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanming Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanming Wu. The network helps show where Shanming Wu may publish in the future.

Co-authorship network of co-authors of Shanming Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Shanming Wu. A scholar is included among the top collaborators of Shanming Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanming Wu. Shanming Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Cai, Dachuan, Chen Pan, Shuangsuo Dang, et al.. (2019). Comparison of the long-term efficacy of tenofovir and entecavir in nucleos(t)ide analogue-naïve HBeAg-positive patients with chronic hepatitis B. Medicine. 98(1). e13983–e13983. 30 indexed citations

Wu, Shanming, et al.. (2016). Improving on recommend speed of recommender systems by using expert users. 6. 2425–2430. 1 indexed citations

Zhuang, Yan, Qing Guo, Yunye Liu, et al.. (2014). Long‐term lamivudine treatment achieves regression of advanced liver fibrosis/cirrhosis in patients with chronic hepatitis B. Journal of Gastroenterology and Hepatology. 30(2). 372–378. 28 indexed citations

Jia, Jidong, Jinlin Hou, Deming Tan, et al.. (2013). Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patients. Hepatology International. 8(1). 72–82. 13 indexed citations

Wu, Shanming, Xia-qiu Zhou, Qingbo Zhang, et al.. (2011). [Clinical characteristics of 638 patients infected with hepatitis C virus by post blood transfusion, in Shanghai].. PubMed. 32(4). 388–91. 3 indexed citations

Jia, Jidong, Jinlin Hou, Dao-zhen Xu, et al.. (2007). [The degree of HBV suppression with 24 week telbivudine- or lamivudine-treatment in hepatitis B patients predicts the efficacy of the treatment at week 52].. PubMed. 15(5). 342–5. 3 indexed citations

Chen, Xiaorong, Hua Yao, Yin Jiang, et al.. (2004). [Evaluate of the therapeutic efficiency of the Chinese traditional medicine Gansu granule on chronic hepatitis B].. PubMed. 12(1). 50–50. 5 indexed citations

Lu, Lungen, Minde Zeng, Yimin Mao, et al.. (2003). Oxymatrine therapy for chronic hepatitis B: A randomized double-blind and placebo-controlled multi-center trial. World Journal of Gastroenterology. 9(11). 2480–2480. 69 indexed citations

Lu, Lungen, Minde Zeng, Mobin Wan, et al.. (2003). Grading and staging of hepatic fibrosis, and its relationship with noninvasive diagnostic parameters. World Journal of Gastroenterology. 9(11). 2574–2574. 66 indexed citations

10.

Luo, Chenyu, et al.. (2002). The relationship between staging of hepatic fibrosis and the levels of serum biochemistry.. PubMed. 1(2). 246–8. 8 indexed citations

11.

Gu, Jianren, et al.. (1985). State of hepatitis B virus DNA in leucocytes of hepatitis B patients. Journal of Medical Virology. 17(1). 73–81. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact